FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US

18,284 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 13600 - 13800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.202Serum Creatinineactive2024-02hl7
hl7.fhir.us.registry-protocolsR4ValueSet/SeattleAnginaAsSeattle Angina Answersactivecic2023-11hl7
hl7.fhir.us.davinci-pasR4ValueSet/X12278DiagnosisInformationTypeX12 278 Diagnosis Information Typetrial-use3fm2025-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.635LP(a) Test_ICDactive2025-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7755LTBI Drug Regimen (TB)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7866Lab Test Method (MDRO)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3358Lab Test Name (NND)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7278Lab Test Performed Modifier (CS)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3017Lab Test Result (PHLIP Flu)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6013Lab Test Type (Hepatitis)active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6014Lab Test Type Enzymes (Hepatitis)active2012-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3016Lab Test Order (PHLIP Flu)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.4275Lab Result (Cancer Morphology)active2011-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.50MSI Highactive2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7892Lab Result (Candida auris)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7895Lab Result Carbapenem Resistant Enterobacteriaceactive2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.4024Lab Result (Cysticercosis)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.4067Lab Result (Nontuberculous Mycobacteria)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.4276Lab Result (Pesticide)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7894Lab Test Name (Candida Auris)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7893Lab Test Name Carbapenem Resistant Enterobacteriaactive2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8030Lab Test (Hansen)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7733Lab Test Method (RIBD)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1004Ordered Testactive2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7472Lab Test Type (Arbovirus)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8041Lab Test Type (Leptospirosis)active2021-01
hl7.fhir.us.coreR4ValueSet/us-core-laboratory-test-codesUS Core Laboratory Test Codestrial-use3cgp2022-11hl7
fhir.cdc.opioid-cds-r4R4ValueSet/observation-category-laboratoryObservation Category Laboratoryactive2023-05hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1002Lab Test Result Nameactive2020-01
hl7.fhir.us.breastcancerR3ValueSet/oncology-HER2byFISHVSInterpretationTestsVSBC HER2byFISHVSInterpretationTestsVS ValueSetdraft2018-08hl7
hl7.fhir.us.breastcancerR3ValueSet/oncology-EstrogenReceptorInterpretationTestsVSBC EstrogenReceptorInterpretationTestsVS ValueSetdraft2018-08hl7
hl7.fhir.us.breastcancerR3ValueSet/oncology-HER2byIHCInterpretationTestsVSBC HER2byIHCInterpretationTestsVS ValueSetdraft2018-08hl7
hl7.fhir.us.breastcancerR3ValueSet/oncology-ProgesteroneReceptorInterpretationTestsVSBC ProgesteroneReceptorInterpretationTestsVS ValueSetdraft2018-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1003Observation Methodactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8037Test Type (Brucellosis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3097Present Absent Unknown Not Examinedactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7612Late Clinical Manifestation (STD)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.883PHIN Questionsactive2013-01
signal.core.r4R4ValueSet/questionnaire-ccars-legal-statusQuestionnaire CCARS Legal Statusdraft1pahl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7714Legionella Diagnosis (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7715Legionella Exposure (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7737Legionellosis Serogroup (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7770Length of Time Drug Taken (TB)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7468Length of Gestation in Weeksactive2016-01
hl7.fhir.us.registry-protocolsR4ValueSet/LesionSegmentNumberLesion Segment Numberactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.921Emergency Department Acuityactive2008-01
hl7.fhir.us.mcodeR4ValueSet/mcode-clark-level-value-vsClark Level Value Setactivecic2025-02hl7
signal.core.r4R4ValueSet/questionnaire-answers-statusQuestionnaireResponseStatusdraft3fhir2019-10hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-tnm-distant-metastases-staging-type-max-vsTNM Distant Metastases Staging Type Maximum Value Setactive4cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-tnm-primary-tumor-staging-type-max-vsTNM Primary Tumor Staging Type Maximum Value Setactive4cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-tnm-regional-nodes-staging-type-max-vsTNM Regional Nodes Staging Type Maximum Value Setactive4cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-tnm-stage-group-staging-type-max-vsTNM Stage Group Staging Type Maximum Value Setactive4cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-condition-status-trend-max-vsCondition Status Trend Maximum Value Setactive3cic2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.941Susceptibility Resultactive2008-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.636Lp(a) Test_CPTactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.637LP(a) Testactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.634Lp(a) Test_LOINCactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.633Lp(a) Test_SNOMEDactive2025-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3241Notifiable Event Condition (Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3594Campylobacter Organismactive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.988Countermeasure Encounter Purposeactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.989Countermeasure Encounter Typeactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6047Message Structure (Syndromic Surveillance)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3244Medication Treatment (Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1073Microbiology Test Result Nameactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1107Notification Section Headeractive2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6048Event Type (Syndromic Surveillance)active2012-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6049Message Type (Syndromic Surveillance)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6050Universal ID Type (Syndromic Surveillance)active2012-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8012Activity Type (Brucellosis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3502Infectious Diseaseactive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3501Bacterial Infectious Diseaseactive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3503Pneumonia Diseaseactive2010-01
hl7.fhir.us.davinci-crdR4ValueSet/cardTypeCRD Card Types Value Settrial-use3fm2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3242Risk Factor (Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.877Detailed Ethnicityactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3032Notifiable Condition (Hepatitis)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1019Non-paint lead source - hobby relatedactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7464Insect Repellantactive2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7759Medication (TB)active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7923Medication Treatment (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7351Lab Test Performed Modifier (NND)active2014-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7462Prenatal Diagnostic Proceduresactive2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1018Non Paint Lead Sourceactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7447Nationally Notifiable Event Code (Generic)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7276Nationally Notifiable Event Code (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1015Nationally Notifiable Disease Surveillance System (NNDSS) & Other Conditions of Public Health Importanceactive2021-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1016Nationally Notifiable Infectious Disease reportable to the Nationally Notifiable Disease Surveillance Systemactive2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3589Observation Identifier (Syndromic Surveillance)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3000PHLIP Questions (Flu)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3245Radiology Lab Test (Flu)active2009-01
hl7.fhir.us.davinci-crdR4ValueSet/DocReasonCRD Coverage Information Documentation Reason Value Settrial-use1fm2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.834Allergenactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3246Specimen (Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7488Specimen Type (Arbovirus)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7653Specimen Type (CRS)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7841Specimen Type (Lyme)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7657Specimen Type (Rubella)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7463Specimen Type (Zika)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7885Public Site of Exposure (CO)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7896Residential Site of Exposure (CO)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7784Diet Type (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7995Diet Type (Anthrax)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3270Therapy 7 Days Prior or After Illness Onset (Pediatric Flu)active2009-01
rapportendoscopiequebec.testR4ValueSet/ca-qc-endo-valueset-villeendoVilleEndoactive2024-05hl7
rapportendoscopiequebec.testR4ValueSet/ca-qc-endo-valueset-voieadministrationendoVoieAdministrationEndoactive2024-05hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7801Signs and Symptoms (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7817Type of Dairy Product (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7782Deli Meats (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7783Deli Salads (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7789Fruit (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7792Illness (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7786Food (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7796Patient Type (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7785Extended Race Group (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7805Yes No None (Listeria)active2018-01
hl7.fhir.us.registry-protocolsR4ValueSet/AntiarrhythmicsAll Antiarrhythmicsactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3308Complications (Malaria)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3268Acute Illness Complications (Pediatric Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3269Underlying Conditions (Pediatric Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3311Medication Prophylaxis (Malaria)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3312Medication Treatment (Malaria)active2019-01
hl7.fhir.us.pq-cmc-fdaR5ValueSet/cmc-specification-types-vsSpecification Section Type Terminologytrial-use2brr2025-07hl7
ca.on.dhdr.r4.v4R4ValueSet/accdr-vs-location-physical-typeLocation Physical Typeactivehl7
hl7.fhir.us.registry-protocolsR4ValueSet/LocationInGraftLocation in the CABG Graftactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8009Exposure Location (Brucellosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7988Location Type (Leptospirosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7797Birth Location (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1052Transmission Setting (NND)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3201Geographical location historyactive2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3209Exposure Locationactive2009-01
hl7.fhir.us.registry-protocolsR4ValueSet/ValvularStenosisValvular Stenosisactivecic2023-11hl7
hl7.fhir.us.breast-radiologyR4ValueSet/LymphNodeAbnormalityTypeVSLymph Node Type ValueSetactive2022-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1007Major Site of Disease (TB)active2008-01
hl7.fhir.us.registry-protocolsR4ValueSet/CABGTypeCoronary Artery Bypass Graft Typeactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/StentTypeCathPCI List of Stent Typesactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3152Whole Cell ELISA Manufacturer (VZ)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3153gp ELISA Manufacturer (VZ)active2008-01
fhir.mamaTotoR4ValueSet/maritalStatusVSMarital Statusdraft2025-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.1.11.12212Marital Status Value Setactive2009-01
signal.core.r4R4ValueSet/questionnaire-ccars-marital-statusQuestionnaire CCARS Marital Statusdraft1pahl7
hl7.fhir.us.splR5ValueSet/valueset-splMarketingStatusesSPL Marketing Statuses ValueSettrial-use1brr2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7848Exposure Setting Master (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7845Serotype Master (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7846Lab Test Interpretation Master (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7847Lab Test Type Master (RIBD)active2018-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1138.564CABG or PCI Procedureactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1138.565CABG or PCI Procedureactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1138.566CABG or PCI Procedureactive2018-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.120.11.1007HIV 1active2024-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3126Genotype (Measles)active2008-01
hl7.fhir.us.davinci-vbprR4ValueSet/vbp-measure-populationVBP Measure Population Typetrial-use1cqi2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7669Food Processing Method (Trich)active2018-01
hl7.fhir.us.registry-protocolsR4ValueSet/MechanicalVentricularSupportTimingMechanical Ventricular Support Timingactivecic2023-11hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/MedDRATransfusionAdverseEventVSTransfusion-related Adverse Eventsdraft2023-08hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/MedDRAVaccinationAdverseEventVSVaccination-related Adverse Eventsdraft2023-08hl7
signal.core.r4R4ValueSet/questionnaire-ccars-rae-aso-identification-codesQuestionnaire CCARS RAE ASO Identification Codesdraft1pahl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7636Medical History (FDD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7795Medical History (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.916Medical Specialty (HL7)active2008-01
hl7.fhir.us.pacio-adiR4ValueSet/ADIDMedicallyAssistedHydrationNutritionOrderGroupingVSMedically Assisted Hydration Order Groupingactivepe2025-07hl7
hl7.fhir.us.pacio-adiR4ValueSet/ADIDMedicallyAssistedHydrationNutritionOrderVSMedically Assisted Hydration Orderactivepe2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7932Duration Units (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7931Medication Frequency Unit (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7635Medication Administered (FDD)active2017-01
fhir.cdc.opioid-cds-r4R4ValueSet/methadone-medicationsMethadone medicationsactive2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8024Medication Completed (Brucellosis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7972Medication (Brucellosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7839Medication Received (Lyme)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3147Medication Received (VZ)active2008-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.183Findings Related to Medication Management, Medication relatedactive2021-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7929Medication Route (STD)active2020-01
fhir.cdc.opioid-cds-r4R4ValueSet/cns-depressant-medicationsCNS depressant medicationsactive2025-02hl7
fhir.cdc.opioid-cds-r4R4ValueSet/non-synthetic-opioid-medicationsNon-synthetic opioid medicationsactive2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7710Medication Pre-Treatment (RIBD)active2018-01
fhir.acme.affiliate-reportR4ValueSet/member-number-type-vsMember Number Type VSdraft2025-05hl7
signal.core.r4R4ValueSet/questionnaire-ccars-history-of-mental-health-servicesQuestionnaire CCARS History Of Mental Health Servicesdraft1pahl7
hl7.fhir.us.dme-ordersR4ValueSet/PAOx-Message-EventPAO Message Eventdraft2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.15MetabolicSyndromeConditionactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.9Metabolic Syndrome ICD10active2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.12Metabolic Syndrome LOINCactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.33Metastatic Breast Canceractive2023-09hl7
hl7.fhir.us.codex-radiation-therapyR4ValueSet/codexrt-radiotherapy-respiratory-motion-management-vsRadiotherapy Respiratory Motion Management Value Setactivecgp2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7698Gestational Age Determination (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7199Detection Method (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7696Detection Method (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7671Food Cooking Method (Trich)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3083Food Cooking Method (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7930Route of Administration (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3084Food Processing Method (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7727Titer Test Method (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3142Test Method EIA IgMactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7105VPD Specimen Collection Methodactive2020-01
hl7.cda.us.eyecareR5ValueSet/RefractionMethodCodesRefraction Method Codesdraft2024-02hl7
hl7.cda.us.eyecareR5ValueSet/VisualAcuityMethodCodesVisual Acuity Method Codesdraft2024-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3257Surveillance Method (Novel Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1009Microorganismactive2019-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7200Lab Results (STD)active2020-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.49MSI Testingactive2023-11hl7
hl7.fhir.us.military-serviceR4ValueSet/military-service-branch-vsMilitary Branch Value Setactive2023-05hl7